|
⚲
|
| Keyboard |
| Thomas Dietz | |
|---|---|
| Firm | |
| Address | 47 Thorndike Street Suite B11 Cambridge, MA 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Leap Therapeutics Inc | 021-475708 | Director | 77.2 M of 77.2 M |
||
| Agbiome LLC | 021-317048 | Director | 65.0 M of 65.0 M |
||
| Leap Therapeutics Inc | 021-299736 | Director | 18.0 M of 18.0 M |
||
| Eiger Biopharmaceuticals Inc | 021-262254 | Director | 3.0 M of 3.0 M |
||
| Eiger Biopharmaceuticals Inc | 021-251688 | Director | 6.0 M of 6.0 M |
||
| Agbiome LLC | 021-246215 | Director | 34.5 M of 34.5 M |
||
| Galleon Pharmaceuticals Inc | 021-206691 | Director | 1.5 M of 1.5 M |
||
| Virobay Inc | 021-143597 | Director | 18.0 M of 18.5 M |
||